Morepen Laboratories net profit up to Rs 168 million in Q2

By Pradeep Rane | 14 Oct 2002

1

Mumbai: Morepen Laboratories has posted a net profit of Rs 167.5 million for the quarter ended 30 September 2002 as compared to Rs 133.1 million for the quarter ended 30 September 2001.

The total income has increased from Rs 1,193.7 million for quarter ended 30 September 2001 to Rs 1,493.5 million for quarter ended 30 September 2002.

Says Morepen Laboratories chairman and managing director Sushil Suri: “We recently went for a series of acquisitions to consolidate our position in the market. The acquisitions include Lemolate, a premium brand of Yash Pharma Laboratories, in the cough-and-cold category, and Burnol and Lifespring. The acquisitions have been made under the Dr Morepen umbrella.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more